Flora Growth Stock (NASDAQ:FLGC)


ForecastRevenueOwnershipFinancialsChart

Previous Close

$11.48

52W Range

$5.86 - $47.00

50D Avg

$7.86

200D Avg

$18.24

Market Cap

$4.23M

Avg Vol (3M)

$96.64K

Beta

1.90

Div Yield

-

FLGC Company Profile


Flora Growth Corp., along with its various subsidiaries, operates as a global enterprise specializing in the cultivation, processing, and advancement of medicinal cannabis and its derived products. The company distributes these offerings to a broad international client base, including pharmacies, medical clinics, and cosmetic companies. Its extensive portfolio encompasses a range of activities and products: Cannabis and Derivatives: This core segment involves the production and supply of medical-grade cannabis oil, alongside a spectrum of cannabis-infused medical and wellness items. Health and Personal Care: They develop and market skincare and beauty products, plant-based pharmaceuticals, phytotherapeutics, and dietary supplements. Furthermore, their offerings include a wide array of cannabidiol (CBD) products like edibles (gummies), topical applications, tinctures, and vaping solutions, as well as general lifestyle wellness items such as bath and body products, pet care, and sports recovery aids. Ancillary and Lifestyle Products: Flora Growth designs and sells loungewear crafted from hemp-derived fabrics and provides accessories for cannabis consumption, personal storage, and travel, catering to both vape and dry herb users. Food and Beverages: The company's diversified operations also include the distribution of juices, gourmet chocolates (featuring exotic fruits coated in chocolate and chocolate bars), and dried fruits, beans, and pulp sourced from Amazonian regions. These items reach consumers through various retail channels, including supermarkets, discount stores, coffee shops, restaurants, and airports. They also manufacture, promote, and distribute other beverage products. Pharmaceutical Initiatives: Flora Growth is involved in creating and distributing pain relief formulations and is actively pursuing the development of a pharmaceutical cannabinoid formula intended for Sars-Cov-2 prevention. Their products are marketed under several distinct brands, including JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya. Established in 2019, Flora Growth Corp. maintains its corporate headquarters in Toronto, Canada.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

64

IPO Date

May 11, 2021

Website

FLGC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 21
Pharmaceuticals and Nutraceuticals$2.34M

Fiscal year ends in Dec 25 | Currency in USD

FLGC Financial Summary


Dec 25Dec 24Dec 23
Revenue$14.50M$59.51M$76.07M
Operating Income$-4.46M$-15.64M$-50.35M
Net Income$-4.42M$-15.91M$-57.04M
EBITDA$-3.90M$-15.10M$-45.87M
Basic EPS-$-1.30$-7.33
Diluted EPS-$-1.30$-7.33

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 24May 15, 24 | 12:00 AM
Q2 23Aug 15, 23 | 9:00 AM
Q4 22Apr 03, 23 | 8:00 AM

Peer Comparison


TickerCompany
AKANAkanda Corp.
AMIXAutonomix Medical, Inc. Common Stock
KALAKALA BIO, Inc.
KZIAKazia Therapeutics Limited
ENSCEnsysce Biosciences, Inc.
RDHLRedHill Biopharma Ltd.